#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    X-linked lymphoproliferative syndrome Renal disorder Angiosarcoma non-metastatic Porphyria non-acute Primary mediastinal large B-cell lymphoma Neuromyelitis optica spectrum disorder Haemolytic uraemic syndrome Alport's syndrome Osteosarcoma Ventricular fibrillation Stargardt's disease Small cell lung cancer limited stage Leiomyosarcoma recurrent Urethral valves Stress cardiomyopathy More trials…

    Learn about Rare Diseases

    Angiosarcoma recurrent – Life with Disease Pituitary-dependent Cushing’s syndrome – Life with Disease Pulmonary sarcoidosis – Diagnostics Pemphigus Glomerulonephritis rapidly progressive – Life with Disease Skin angiosarcoma – Life with Disease Mucopolysaccharidosis I – Basic Information Ewing’s sarcoma metastatic – Trials in Disease Primary biliary cholangitis Angiosarcoma non-metastatic – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Prednisolone Sodium Succinate IHMA-2121908-1 S227928 Cx-039776 Forimtamig Sulfur Hexafluoride Efgartigimod Alfa Ranitidine Mk-1167 Sar441566 Lna043 Ripretinib TAZAROTENE Insulin Aspart Clavulanic Acid Livmoniplimab Mitoxantrone Calcitriol Petrelintide Allo-501A More therapies…

    Learn about Your Condition

    Metastasis Neoplasm malignant Thalassaemia Placenta praevia Bronchitis Cataract Von Hippel-Lindau disease Graft versus host disease Hepatotoxicity Endocarditis enterococcal Metastases to meninges B-cell type acute leukaemia Yellow fever Transitional cell carcinoma Pneumothorax More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Radioembolization Combined with Cisplatin, Gemcitabine and Durvalumab Treatment in Patients with Unresectable Liver Cholangiocarcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Cisplatin
    • Durvalumab
    • Gemcitabine
    Italy

  • Study on the Effects of Selumetinib, Bicalutamide, and Olaparib in Patients with Metastatic Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast neoplasm
    Investigated Drugs:
    • Selumetinib
    • Bicalutamide
    • Olaparib
    Italy

  • Study on the Safety and Effectiveness of EIK1001 and Pembrolizumab for Patients with Advanced Melanoma

    Recruiting

    4 1 1
    Investigated Drugs:
    • Pembrolizumab
    • Resiquimod Sulfate
    Austria Belgium Bulgaria Czechia Denmark Finland +9

  • Study of Ruxolitinib and Chemotherapy Drug Combination for Children with Acute Lymphoblastic Leukemia and JAK/STAT Pathway Activation

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Methotrexate Disodium
    • Dexamethasone Phosphate
    • Vindesine Sulfate
    Poland

  • Study of [18F]AlF-NOTA-Octreotide for Carotid Artery Disease in Patients with Recent Stroke or TIA

    Recruiting

    2 1 1
    Investigated Diseases:
    • Carotid arteriosclerosis
    Investigated Drugs:
    • [18F]Alf-Nota-Octreotide
    Belgium

  • Study on the Effects of Ferric Carboxymaltose on Heart Health and Quality of Life in Patients with Recent Heart Attack and Iron Deficiency

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myocardial infarction
    Investigated Drugs:
    • Ferric Carboxymaltose
    • Sodium Chloride
    Poland
Previous Page
1 … 421 422 423 424 425 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!